OneSource and Formycon Partner to Expand Global Biosimilar Manufacturing Capabilities
MM Desk
18 July, 2026
OneSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), a global multi-modality specialty pharmaceutical contract development
